Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus

被引:63
|
作者
Elias, LLK
AntunesRodrigues, J
Elias, PCL
Moreira, AC
机构
[1] FAC MED, DEPT MED, DIV ENDOCRINOL, BR-14049900 RIBEIRAO PRETO, SP, BRAZIL
[2] FAC MED, DEPT PHYSIOL, BR-14049900 RIBEIRAO PRETO, SP, BRAZIL
来源
关键词
D O I
10.1210/jc.82.4.1243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present study was to examine the effect of changes in plasma osmolality (pOsm) on the responses of the pituitary-adrenal axis to CRH and atrial natriuretic peptide (ANP) release in patients with central diabetes insipidus (DI). Eight normal subjects and six DI patients were subjected to human CRH (hCRH) (1 mu g/kg) stimulation alone or associated with isotonic volume loading (0.9% NaCl, 12 mL . kg . 60 min) or an osmotic stimulus (5% NaCl, 0.06 mL . kg/min . 120 min). The DI group showed significantly increased pOsm and undetectable or low plasma arginine vasopressin (AVP) during all tests. In the control group, pOsm and plasma AVP increased only during the osmotic stimulus. The DI group presented lower plasma ANP levels than controls during osmotic stimulus and isotonic volume loading. The lower ANP secretion in DI patients corroborates the importance of neurohypophyseal hormones in ANP regulation. Basal plasma ACTH and cortisol levels did not differ between controls and DI. The latter group presented a higher ACTH response than controls during stimulation with hCRH alone [area under the curve (AUG) 1138 +/- 99 vs. 709 +/- 62 pmol . L/min] and hCRH/5% NaCl (AUG 1602 +/- 209 vs. 1158 +/- 187 pmol . L . min). The DI cortisol AUC were higher than controls during stimulation with hCRH alone (65,471 +/- 6,070 vs. 48,062 +/- 3,476 nmol . L . min) and hCRH/5% NaCl(89,005 +/- 10,043 vs. 62,105 +/- 5,600 nmol . L . min). The highest ACTH and cortisol responses to hCRH in both groups were obtained with hCRH/5% NaCl. There was a significant correlation between mean pOsm and ACTH response to hCRH (r = 0.62). The increased responses to hCRH with increasing pOsm were present in control subjects and in patients with DI. However, at any given level of pOsm, there was no difference in ACTH response between controls and DI. These data indicate that the acute increases in pOsm augmented the ACTH and cortisol responses to hCRH that involve other factors besides magnocellular AVP.
引用
收藏
页码:1243 / 1247
页数:5
相关论文
共 50 条
  • [1] Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men
    Bierwolf, C
    Burgemeister, A
    Lüthke, K
    Born, J
    Fehm, HL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1151 - 1157
  • [2] GLUCOCORTICOID THERAPY AND PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE
    AXELROD, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (04): : 282 - 283
  • [3] Pituitary-adrenal responses to human corticotropin-releasing hormone in critically ill patients
    Dimopoulou, Ioanna
    Alevizopoulou, Panagiota
    Dafni, Urania
    Orfanos, Stylianos
    Livaditi, Olga
    Tzanela, Marinella
    Kotanidou, Anastasia
    Souvatzoglou, Emmanouil
    Kopterides, Petros
    Mavrou, Irini
    Thalassinos, Nikolaos
    Roussos, Charis
    Armaganidis, Apostolos
    Tsagarakis, Stylianos
    INTENSIVE CARE MEDICINE, 2007, 33 (03) : 454 - 459
  • [4] Pituitary-adrenal responses to human corticotropin-releasing hormone in critically ill patients
    Ioanna Dimopoulou
    Panagiota Alevizopoulou
    Urania Dafni
    Stylianos Orfanos
    Olga Livaditi
    Marinella Tzanela
    Anastasia Kotanidou
    Emmanouil Souvatzoglou
    Petros Kopterides
    Irini Mavrou
    Nikolaos Thalassinos
    Charis Roussos
    Apostolos Armaganidis
    Stylianos Tsagarakis
    Intensive Care Medicine, 2007, 33 : 454 - 459
  • [5] THE EFFECT OF LONG-TERM GLUCOCORTICOID THERAPY ON PITUITARY-ADRENAL RESPONSES TO EXOGENOUS CORTICOTROPIN-RELEASING HORMONE
    SCHLAGHECKE, R
    KORNELY, E
    SANTEN, RT
    RIDDERSKAMP, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04): : 226 - 230
  • [6] PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN DIFFERENT DEGREES OF ADRENAL 21-HYDROXYLASE DEFICIENCY
    MOREIRA, AC
    ELIAS, LLK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (01): : 198 - 203
  • [7] PITUITARY-ADRENAL RESPONSIVENESS TO CORTICOTROPIN-RELEASING HORMONE IN CHRONIC UREMIC PATIENTS
    SIAMOPOULOS, KC
    DARDAMANIS, M
    KYRIAKI, D
    PAPPAS, M
    SFEROPOULOS, G
    ALEVISOU, V
    PERITONEAL DIALYSIS INTERNATIONAL, 1990, 10 (02): : 153 - 156
  • [8] CORTICOTROPIN-RELEASING HORMONE AND PITUITARY-ADRENAL HORMONES IN PREGNANCIES COMPLICATED BY CHRONIC HYPERTENSION
    WARREN, WB
    GUREWITSCH, ED
    GOLAND, RS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (02) : 661 - 666
  • [9] A COMPARISON OF THE EFFECTS OF HUMAN AND OVINE CORTICOTROPIN-RELEASING HORMONE ON THE PITUITARY-ADRENAL AXIS
    TRAINER, PJ
    FARIA, M
    NEWELLPRICE, J
    BROWNE, P
    KOPELMAN, P
    COY, DH
    BESSER, GM
    GROSSMAN, AB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02): : 412 - 417
  • [10] Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
    Arlt, J
    Jahn, H
    Kellner, M
    Ströhle, A
    Yassouridis, A
    Wiedemann, K
    NEUROPEPTIDES, 2003, 37 (06) : 362 - 368